Salvia plebeia suppresses atopic dermatitis-like skin lesions

American Journal of Chinese Medicine

Volumn 42, Issue 4, 2014, Pages 967-985

  Choi, Jin Kyeong ^a   Oh, Hyun Mee ^b   Lee, Soyoung ^a   Kwon, Taeg Kyu ^c   Shin, Tae Yong ^d   Rho, Mun Chual ^b   Kim, Sang Hyun ^a  

^a Kyungpook National University   (South Korea)

^b Korea Research Institute of Bioscience and Biotechnology (KRIBB)   (South Korea)

^c Woosuk University   (South Korea)

^d Keimyung University   (South Korea)

Author keywords

Atopic Dermatitis; Keratinocytes; Salvia plebeia

Indexed keywords

1 CHLORO 2,4 DINITROBENZENE; DERMATOLOGICAL AGENT; GAMMA INTERFERON; HOUSE DUST ALLERGEN; IMMUNOGLOBULIN E; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; IMMUNOGLOBULIN G2A; INTERLEUKIN 1BETA; INTERLEUKIN 4; INTERLEUKIN 6; MACROPHAGE DERIVED CHEMOKINE; MITOGEN ACTIVATED PROTEIN KINASE; PLANT EXTRACT; SALVIA PLEBEIA EXTRACT; STAT1 PROTEIN; THYMUS AND ACTIVATION REGULATED CHEMOKINE; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; ANTIECZEMA AGENT; ANTIINFLAMMATORY AGENT; CHEMOKINE; CYTOKINE; HISTAMINE; INTERLEUKIN 13; INTERLEUKIN 17; INTERLEUKIN 31; TACROLIMUS; AUTACOID; HERBACEOUS AGENT; IMMUNOGLOBULIN G; SALVIA EXTRACT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ATOPIC DERMATITIS; CD4+ T LYMPHOCYTE; CELL EXPANSION; CELL INFILTRATION; CONTROLLED STUDY; DERMATOPHAGOIDES FARINAE; DOWN REGULATION; DRUG MECHANISM; EAR; FEMALE; HISTAMINE BLOOD LEVEL; HISTOPATHOLOGY; HUMAN; HUMAN CELL; IMMUNOGLOBULIN BLOOD LEVEL; IMMUNOPHENOTYPING; KERATINOCYTE; LYMPH NODE; MAST CELL; MOUSE; NONHUMAN; SALVIA; SALVIA PLEBEIA; SKIN DEFECT; TH1 CELL; TH17 CELL; TH2 CELL; THICKNESS; ANIMAL CELL; ANTIINFLAMMATORY ACTIVITY; CYTOKINE PRODUCTION; DRUG EFFICACY; EAR EDEMA; ETHNOPHARMACOLOGY; HERBAL MEDICINE; PROTEIN EXPRESSION; ANIMAL; BAGG ALBINO MOUSE; BLOOD; CELL CULTURE; DERMATITIS, ATOPIC; DISEASE MODEL; EXTERNAL EAR; IMMUNOLOGY; METABOLISM; ORAL DRUG ADMINISTRATION; PATHOLOGY; PHYTOTHERAPY; SKIN; T LYMPHOCYTE;

ADMINISTRATION, ORAL; ANIMALS; CELLS, CULTURED; CYTOKINES; DERMATITIS, ATOPIC; DISEASE MODELS, ANIMAL; DRUGS, CHINESE HERBAL; EAR, EXTERNAL; FEMALE; HISTAMINE; HUMANS; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G; INFLAMMATION MEDIATORS; KERATINOCYTES; LYMPH NODES; MAST CELLS; MICE, INBRED BALB C; MITOGEN-ACTIVATED PROTEIN KINASES; NF-KAPPA B; PHYTOTHERAPY; SALVIA; SKIN; T-LYMPHOCYTES;

EID: 84904299467     PISSN: 0192415X     EISSN: None     Source Type: Journal    
DOI: 10.1142/S0192415X1450061X     Document Type: Article

References (49)

1. Akdis, C.A., M. Akdis, T. Bieber, C. Bindslev-Jensen, M. Boguniewicz, P. Eigenmann, Q. Hamid, A. Kapp, D.Y. Leung, J. Lipozencic, T.A. Luger, A. Muraro, N. Novak, T.A. Platts-Mills, L. Rosenwasser, A. Scheynius, F.E. Simons, J. Spergel, K. Turjanmaa, U. Wahn, S. Weidinger, T. Werfel and T. Zuberbier. Diagnosis and treatment of atopic dermatitis in children and adults: European Academy of Allergology and Clinical Immunology/American Academy of Allergy, Asthma and Immunology/PRACTALL Consensus Report. J. Allergy Clin. Immunol. 118: 152-169, 2006.
2. Arbabi, S. and R.V. Maier. Mitogen-activated protein kinases. Crit. Care Med. 30: S74-S79, 2002.
3. Bae, Y., S. Lee and S.H. Kim. Chrysin suppresses mast cell-mediated allergic inflammation: Involvement of calcium, caspase-1 and nuclear factor-kappaB. Toxicol. Appl. Pharmacol. 254: 56-64, 2011.
4. Bieber, T. Atopic dermatitis. Ann. Dermatol. 22: 125-137, 2010.
5. Choi, J.K. and S.H. Kim. Rutin suppresses atopic dermatitis and allergic contact dermatitis. Exp. Biol. Med. (Maywood) 238: 410-417, 2013.
6. Choi, J.K., H.M. Oh, S. Lee, J.W. Park, D. Khang, S.W. Lee, W.S. Lee, M.C. Rho and S.H. Kim. Oleanolic acid acetate inhibits atopic dermatitis and allergic contact dermatitis in a murine model. Toxicol. Appl. Pharmacol. 269: 72-80, 2013.
7. Dai, X., K. Sayama, M. Tohyama, Y. Shirakata, Y. Hanakawa, S. Tokumaru, L. Yang, S. Hirakawa and K. Hashimoto. Mite allergen is a danger signal for the skin via activation of inflammasome in keratinocytes. J. Allergy Clin. Immunol. 127: 806-814 e801-e804, 2011.
8. Dhar, A., M.R. Young and N.H. Colburn. The role of AP-1, NF-kappaB and ROS/NOS in skin carcinogenesis: The JB6 model is predictive. Mol. Cell. Biochem. 234-235: 185-193, 2002.
9. Dokmeci, E. and C.A. Herrick. The immune system and atopic dermatitis. Semin. Cutan. Med. Surg. 27: 138-143, 2008.
10. Girolomoni, G. and S. Pastore. Epithelial cells and atopic diseases. Curr. Allergy Asthma. Rep. 1: 481-482, 2001.
11. Gittler, J.K., A. Shemer, M. Suarez-Farinas, J. Fuentes-Duculan, K.J. Gulewicz, C.Q. Wang, H. Mitsui, I. Cardinale, de Guzman Strong C., J.G. Krueger and E. Guttman-Yassky. Progressive activation of T(H)2/T(H)22 cytokines and selective epidermal proteins characterizes acute and chronic atopic dermatitis. J. Allergy Clin. Immunol. 130: 1344-1354, 2012.
12. Greaves, M.W. Antihistamines in dermatology. Skin. Pharmacol. Physiol. 18: 220-229, 2005.
13. Gu, L.W. and X.C. Weng. Antioxidant activity and components of Salvia plebeia R. Br.-A Chinese herb. Food. Chem. 73: 299-305, 2001.
14. Guttman-Yassky, E., K.E. Nograles and J.G. Krueger. Contrasting pathogenesis of atopic dermatitis and psoriasis-Part I: Clinical and pathologic concepts. J. Allergy Clin. Immunol. 127: 1110-1118, 2011.
15. Iwaoka, E., H. Oku, M. Iinuma and K. Ishiguro. Allergy-preventive effects of the flowers of Im-patiens textori. Biol. Pharm. Bull. 33: 714-716, 2010.
16. Jahnz-Rozyk, K., T. Targowski, E. Paluchowska, W. Owczarek and A. Kucharczyk. Serum thymus and activation-regulated chemokine, macrophage-derived chemokine and eotaxin as markers of severity of atopic dermatitis. Allergy 60: 685-688, 2005.
17. Jin, H., L. Kumar, C. Mathias, D. Zurakowski, H. Oettgen, L. Gorelik and R. Geha. Toll-like receptor 2 is important for the T(H)1 response to cutaneous sensitization. J. Allergy Clin. Immunol. 123: 875-882, e871, 2009.
18. Jin, X.F., Y.H. Lu, D.Z. Wei and Z.T. Wang. Chemical fingerprint and quantitative analysis of Salvia plebeia R. Br. by high-performance liquid chromatography. J. Pharm. Biomed. Anal. 48: 100-104, 2008.
19. Kaiko, G.E. and P.S. Foster. New insights into the generation of Th2 immunity and potential therapeutic targets for the treatment of asthma. Curr. Opin. Allergy Clin. Immunol. 11: 39-45, 2011.
20. Kakinuma, T., K. Nakamura, M. Wakugawa, H. Mitsui, Y. Tada, H. Saeki, H. Torii, M. Komine, A. Asahina and K. Tamaki. Serum macrophage-derived chemokine (MDC) levels are closely related with the disease activity of atopic dermatitis. Clin. Exp. Immunol. 127: 270-273, 2002.
21. Kanda, N., T. Shimizu, Y. Tada and S. Watanabe. IL-18 enhances IFN-gamma-induced production of CXCL9, CXCL10, and CXCL11 in human keratinocytes. Eur. J. Immunol. 37: 338-350, 2007.
22. Kawakami, T., T. Ando, M. Kimura, B.S. Wilson and Y. Kawakami. Mast cells in atopic dermatitis. Curr. Opin. Immunol. 21: 666-678, 2009.
23. Kim, H.H., J.S. Yoo, T.Y. Shin and S.H. Kim. Aqueous extract of Mosla chinensis inhibits mast cell-mediated allergic inflammation. Am. J. Chin. Med. 40: 1257-1270, 2012.
24. Kim, S.Y., E.J. Sohn, D.W. Kim, H.J. Jeong, M.J. Kim, H.W. Kang, M.J. Shin, E.H. Ahn, S.W. Kwon, Y.N. Kim, H.J. Kwon, T.Y. Kim, K.S. Lee, J. Park, W.S. Eum and S.Y. Choi. Transduced PEP-1-FK506BP ameliorates atopic dermatitis in NC/Nga mice. J. Invest. Dermatol. 131: 1477-1485, 2011.
25. Klunker, S., A. Trautmann, M. Akdis, J. Verhagen, P. Schmid-Grendelmeier, K. Blaser and C.A. Akdis. A second step of chemotaxis after transendothelial migration: Keratinocytes undergoing apoptosis release IFN-gamma-inducible protein 10, monokine induced by IFN-gamma, and IFN-gamma-inducible alpha-chemoattractant for T cell chemotaxis toward epidermis in atopic dermatitis. J. Immunol. 171: 1078-1084, 2003.
26. Koga, C, K. Kabashima, N. Shiraishi, M. Kobayashi and Y. Tokura. Possible pathogenic role of Th17 cells for atopic dermatitis. J. Invest. Dermatol. 128: 2625-2630, 2008.
27. Kolls, J.K., P.B. McCray, Jr. and Y.R. Chan. Cytokine-mediated regulation of antimicrobial proteins. Nat. Rev. Immunol. 8: 829-835, 2008.
28. Kwon, D.J., Y.S. Bae, S.M. Ju, A.R. Goh, G.S. Youn, S.Y. Choi and J. Park. Casuarinin suppresses TARC/CCL17 and MDC/CCL22 production via blockade of NF-kappaB and STAT1 activation in HaCaT cells. Biochem. Biophys. Res. Commun. 417: 1254-1259, 2012.
29. + T cells by probiotics administration suppresses immune disorders. Proc. Natl. Acad. Sci. USA 107: 2159-2164, 2010.
30. Lee, S., H.S. Yun and S.H. Kim. The comparative effects of mesoporous silica nanoparticles and colloidal silica on inflammation and apoptosis. Biomaterials 32: 9434-9443, 2011.
31. Leung, D.Y. and T. Bieber. Atopic dermatitis. Lancet 361: 151-160, 2003.
32. Leung, D.Y.M., M. Boguniewicz, M.D. Howell, I. Nomura and O.A. Hamid. New insights into atopic dermatitis. J. Clin. Invest. 113: 651-657, 2004.
33. Lu, Y. and L.Y. Foo. Polyphenolics of Salvia-A review. Phytochemistry 59: 117-140, 2002.
34. Nader, M.A. Caffeic acid phenethyl ester attenuates IgE-induced immediate allergic reaction. Inflammopharmacology 21: 169-176, 2013.
35. Neis, M.M., B. Peters, A. Dreuw, J. Wenzel, T. Bieber, C. Mauch, T. Krieg, S. Stanzel, P.C. Heinrich, H.F. Merk, A. Bosio, J.M. Baron and H.M. Hermanns. Enhanced expression levels of IL-31 correlate with IL-4 and IL-13 in atopic and allergic contact dermatitis. J. Allergy Clin. Immunol. 118: 930-937, 2006.
36. Nugroho, A., M.H. Kim, J. Choi, N.I. Baek and H.J. Park. In vivo sedative and gastroprotective activities of Salvia plebeia extract and its composition of polyphenols. Arch. Pharm. Res. 35: 1403-1411, 2012.
37. Oka, T., E.J. Rios, M. Tsai, J. Kalesnikoff and S.J. Galli. Rapid desensitization induces internalization of antigen-specific IgE on mouse mast cells. J. Allergy Clin. Immunol. 132(4): 922-932, 2013.
38. Oyoshi, M.K., R. He, L. Kumar, J. Yoon and R.S. Geha. Cellular and molecular mechanisms in atopic dermatitis. Adv. Immunol. 102: 135-226, 2009.
39. Qu, X.J., X. Xia, Y.S. Wang, M.J. Song, L.L. Liu, Y.Y. Xie, Y.N. Cheng, X.J. Liu, L.L. Qiu, L. Xiang, J.J. Gao, X.F. Zhang and S.X. Cui. Protective effects of Salvia plebeia compound homoplantaginin on hepatocyte injury. Food. Chem. Toxicol. 47: 1710-1715, 2009.
40. Reiner, S.L. Development in motion: Helper T cells at work. Cell. 129: 33-36, 2007.
41. Schmid-Grendelmeier, P., D. Simon, H.U. Simon, C.A. Akdis and B. Wuthrich. Epidemiology, clinical features, and immunology of the "intrinsic" (non-IgE-mediated) type of atopic dermatitis (constitutional dermatitis). Allergy 56: 841-849, 2001.
42. Shin, T.Y. and H.M. Kim. Inhibition of immediate-type allergic reactions by the aqueous extract of Salvia plebeia. Immunopharmacol. Immunotoxicol. 24: 303-314, 2002.
43. Shimada, Y., K. Takehara and S. Sato. Both Th2 and Th1 chemokines (TARC/CCL17, MDC/CCL22, and Mig/CXCL9) are elevated in sera from patients with atopic dermatitis. J. Der-matol. Sci. 34: 201-208, 2004.
44. Spergel, J.M., E. Mizoguchi, H. Oettgen, A.K. Bhan and R.S. Geha. Roles of TH1 and TH2 cyto-kines in a murine model of allergic dermatitis. J. Clin. Invest. 103: 1103-1111, 1999.
45. Takada, Y., F.R. Khuri and B.B. Aggarwal. Protein farnesyltransferase inhibitor (SCH 66336) abolishes NF-kappaB activation induced by various carcinogens and inflammatory stimuli leading to suppression of NF-kappaB-regulated gene expression and up-regulation of apo-ptosis. J. Biol. Chem. 279: 26287-26299, 2004.
46. Trautmann, A., M. Akdis, P. Schmid-Grendelmeier, R. Disch, E.B. Brocker, K. Blaser and C.A. Akdis. Targeting keratinocyte apoptosis in the treatment of atopic dermatitis and allergic contact dermatitis. J. Allergy Clin. Immunol. 108: 839-846, 2001.
47. Vestergaard, C., K. Bang, B. Gesser, H. Yoneyama, K. Matsushima and C.G. Larsen. A Th2 chemokine, TARC, produced by keratinocytes may recruit CLA+CCR4+ lymphocytes into lesional atopic dermatitis skin. J. Invest. Dermatol. 115: 640-646, 2000.
48. Xiao, T., S. Kagami, H. Saeki, M. Sugaya, T. Kakinuma, H. Fujita, S. Yano, H. Mitsui, H. Torii, M. Komine, A. Asahina, K. Nakamura and K. Tamaki. Both IL-4 and IL-13 inhibit the TNF-alpha and IFN-gamma enhanced MDC production in a human keratinocyte cell line, HaCaT cells. J. Dermatol. Sci. 31: 111-117, 2003.
49. Yoo, J., M. Omori, D. Gyarmati, B. Zhou, T. Aye, A. Brewer, M.R. Comeau, D.J. Campbell and S.F. Ziegler. Spontaneous atopic dermatitis in mice expressing an inducible thymic stromal lym-phopoietin transgene specifically in the skin. J. Exp. Med. 202: 541-549, 2005.